Understanding Pomalyst® (pomalidomide) capsules

Pomalyst® (pomalidomide) in combination with Dexamethasone was approved by the U.S. Food and Drug Administration (FDA) on February 8, 2013 for relapsed and refractory myeloma.
Purchase this product
FREE